Does patient sex affect the treatment outcome of immune checkpoint inhibitors? A Danish observational melanoma study

The objective of this study was to evaluate whether patient biological sex influences treatment outcomes in patients with metastatic melanoma (MM) undergoing first-line immune checkpoint inhibitor (ICI) therapy.

Source: European Journal of Cancer - May 7, 2024 Category: Cancer & Oncology Authors: S øren Kjær Petersen, Christian Rønn Hansen, Eva Ellebaek, Henrik Schmidt, Charlotte Aaquist Haslund, Christina H. Ruhlmann, Lars Bastholt Tags: Original Research Source Type: research